MichaelBogenschutzMD

Psychiatry • New York, NY

Addiction, Psychopharmacology

Physician

Join to view full profile

Dr. Bogenschutz is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Bogenschutz's full profile

Already have an account?

Office
462 1st Avenue
New York, NY 10016
Phone+1 646-501-4026
Is this information wrong?

Summary

Dr. Michael Bogenschutz is a psychiatrist in New York, NY.

Education & Training

Cambridge Health AllianceResidency, Psychiatry, 1990 - 1994
Harvard Medical SchoolClass of 1990, MD, Cum Laude

Certifications & Licensure

NY State Medical License 2015 - 2026
NM State Medical License 1994 - 2016
American Board of Psychiatry and Neurology Psychiatry
American Board of Psychiatry and Neurology Addiction Psychiatry

Clinical Trials

Leveraging Biomarkers for Personalized Treatment of Alcohol Use Disorder Comorbid With PTSD Start of enrollment: 2019 Oct 16
Recruiting
Phase 2
Roles: Contact
Neurobehavioral Mechanisms of Psilocybin-assisted Treatment for AUD Start of enrollment: 2024 Jul 01
Not yet recruiting
Phase 2
Roles: Principal Investigator, Contact

Publications & Presentations

PubMed

16 citations
MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial.
Jennifer M Mitchell, Marcela Ot'alora G, Bessel van der Kolk, Scott Shannon, Michael Bogenschutz, Yevgeniy Gelfand, Casey Paleos, Christopher R Nicholas, Sylvestre Que...> ;Nature Medicine. 2023 Oct 1
4 citations
MDMA-Assisted Therapy for Severe PTSD: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study.
Jennifer M Mitchell, Michael Bogenschutz, Alia Lilienstein, Charlotte Harrison, Sarah Kleiman, Kelly Parker-Guilbert, Marcela Ot'alora G, Wael Garas, Casey Paleos, Ing...> ;Focus. 2023 Jul 1
1 citations
A Systematic Approach to Standardizing Drinking Outcomes From Timeline Followback Data.
Christina Marini, Nicole S Northover, Noah D Gold, Ursula K Rogers, Kelley C O'Donnell, Babak Tofighi, Stephen Ross, Michael P Bogenschutz> ;Substance Abuse. 2023 Jan 1
2 citations
Clinical Trial Design Challenges and Opportunities for Emerging Treatments for Opioid Use Disorder: A Review.
Brian D Kiluk, Bethea A Kleykamp, Sandra D Comer, Roland R Griffiths, Andrew S Huhn, Matthew W Johnson, Kyle M Kampman, Marco Pravetoni, Kenzie L Preston, Ryan Vandrey...> ;JAMA Psychiatry. 2023 Jan 1
2 citations
A randomized clinical trial of strengths-based case management to link emergency department patients to opioid use disorder treatment.
Michael P Bogenschutz, Ryan McCormack, Richard Rapp, Sarah Meyers-Ohki, Sarah E Mennenga, Amber Regis, Rhonda Kolaric, Richard Glisker, Peter P Greco> ;Journal of Substance Abuse Treatment. 2022 Jul 1
87 citations
Brief intervention for patients with problematic drug use presenting in emergency departments: a randomized clinical trial.
Michael P. Bogenschutz, Dennis M. Donovan, Raul N. Mandler, Harold I. Perl, Alyssa A. Forcehimes, Cameron Crandall, Robert Lindblad, Neal Oden, Gaurav Sharma, Lisa R. ...> ;JAMA Internal Medicine. 2014 Nov 1
Join now to see all

Hospital Affiliations

NYC Health + Hospitals / BellevueNew York, New York

MichaelBogenschutzMD

Dr. Bogenschutz is on Doximity

Summary

Education & Training

Certifications & Licensure

Clinical Trials

Publications & Presentations

Hospital Affiliations

Viewing the full profile is available to verified healthcare professionals only.